# Starling Medical, Inc. — Form D/A

Starling Medical, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2024-12-09. The offering totals $8.9M, of which $8.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-12-09
- Form: D/A
- Accession: 0001935581-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.9M
- Amount sold: $8.9M
- Investors: 40
- Date of first sale: 2024-09-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-524343

## Issuer

- Name: Starling Medical, Inc.
- CIK: 0002031505
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2450 Holcombe Boulevard, HOUSTON, TX, 77021
- Phone: 888-599-8927

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Shana Andrew Barghouti | Director | Houston, TX |
| William Andrew Hendricks | Director | Houston, TX |
| Hannah Andrew McKenney | Director | Houston, TX |
| Kunj Andrew Sheth | Director | Houston, TX |
| Hannah Andrew McKenney | Executive Officer | Houston, TX |
| William Andrew Hagaman | Director | Houston, TX |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2026-03-19](https://search.stillhousedata.com/formd/0002031505-26-000003) | D | $1.8M | $825K |
| [2024-09-18](https://search.stillhousedata.com/formd/0002031505-24-000001) | D | $7.3M | $6.8M |

## More

- [CIK 2031505 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2031505&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001935581-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.